Obesity medications and acquired hypothalamic obesity in adults: A two-case experience
Tirzepatide-based combination therapy was associated with clinically meaningful weight loss and comorbidity improvement in adults with HO. These cases support further study of targeted, multimodal regimens in patients with acquired HO.
Authors
- Jesse Richards (ORCID: https://orcid.org/0009-0004-7985-8882)
- Madisen Fae Dorand (ORCID: https://orcid.org/0000-0003-1973-1009)
- Mahnooor Hassan
- Henry Lang
Institutions
- Tulsa Community College (US)
- Oklahoma State University Medical Center (US)
- University of Tulsa (US)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1016/j.obpill.2026.100246
- Primary Topic
- Regulation of Appetite and Obesity
- Type
- article
- Field-Weighted Citation Impact
- 0.00